DrugPatentWatch Database Preview
BENEFIX Drug Profile
» See Plans and Pricing
Summary for Tradename: BENEFIX
| Patents: | 1 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for BENEFIX |
Recent Clinical Trials for BENEFIX
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Pfizer | Phase 1 |
| Pfizer | Phase 4 |
| Swedish Orphan Biovitrum | Phase 3 |
Patent Text Search: US Patents for BENEFIX
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc | BENEFIX | coagulation factor ix (recombinant) | KIT | 103677 | 1 | 2012-02-01 | Start Trial | Wyeth LLC (Madison, NJ) | 2026-07-13 | search | ||
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for BENEFIX
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 196252 | Start Trial |
| Portugal | 2495307 | Start Trial |
| European Patent Office | 2041270 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
